Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From Germany.

ABSTRACT:

SUBMITTER: Braitsch K 

PROVIDER: S-EPMC9365332 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature